Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Submitted by
admin
on December 7, 2014 - 9:28am
Source:
Yahoo/BusinessWire
News Tags:
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
leukemia
non-Hodgkin's lymphoma
diffuse large B-cell lymphoma
Headline:
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Do Not Allow Advertisers to Use My Personal information
